Fred Alger Management’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-36,313	Closed	-$568K	–	437
2025 Q1	$568K	Buy	+36,313	New	+$568K	﹤0.01%	351
2022 Q4	–	Sell	-26,324	Closed	-$503K	–	519
2022 Q3	$503K	Buy	+26,324	New	+$503K	﹤0.01%	394